Under the FTC’s final order, approved by a 5-0 vote, Stryker must sell all assets associated with total ankle replacements and finger joint implants to DJO Global.
The order settles charges brought by the FTC in November alleging the acquisition would violate antitrust law and result in harm to consumers in the U.S. markets for total ankle replacement and finger joint implants.
The FTC approved the final order after a 30-day public comment period.
More articles on supply chain:
Rural California hospitals struggle with state’s new PPE stockpile mandate
Rare disease patients struggle to find PPE
FDA authorizes first fully at-home COVID-19 test
